Better Therapeutics Inc expected to post a loss of 38  cents a share - Earnings Preview

Better Therapeutics

11/05/2022 14:04

* Better Therapeutics Inc  BTTX.OQ   BTTX.O  is expected
to report
results on May 13.
    * ​Refinitiv's mean analyst estimate for Better Therapeutics
Inc
is for a loss of 38 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 12.8%
in the last three months. ​
    * Wall Street's median 12-month price target for Better
Therapeutics Inc is $17​, above​ its last closing price
of $2.09. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.47       -0.46      -0.71     Missed  -55.5
 Sep. 30 2021  -1.66       -1.66      -0.03     Beat    98.2
                                                        ​
 ​​                                                     
                                                        ​
 This summary was machine generated May 11 at 13:04 GMT.  All
figures in US dollars  unless otherwise stated